Skip to content

Septerna, Inc. SEPN Change in AR

Change in AR at other companies

Amgen logo
AmgenAMGN
-$413M-132%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-$1.49M-212%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$58K
Precigen logo
PrecigenPGEN
$22.49M+12,950%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$4.36M-24.7%
Arrowhead Research logo
Arrowhead ResearchARWR
$212.05M+8,382%

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.62B+319%

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Reported directly by Septerna, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s change in AR?
Septerna, Inc. (SEPN) reported change in AR of $486K in Q1 2026.
How has Septerna, Inc.'s change in AR changed year-over-year?
Septerna, Inc.'s change in AR increased by 515.2% year-over-year, from $79K to $486K.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.